These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 34869561)
1. A Systematic Review and Meta-Analysis Protocol of Chemoablation vs. Transurethral Resection of Bladder Tumor in Patients With Non-Muscle-Invasive Bladder Cancer. Shi X; Feng D; Wei W Front Surg; 2021; 8():753547. PubMed ID: 34869561 [No Abstract] [Full Text] [Related]
2. A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer. Yanagisawa T; Quhal F; Kawada T; Mostafaei H; Motlagh RS; Laukhtina E; Rajwa P; Deimling MV; Bianchi A; Pallauf M; Majdoub M; Pradere B; Moschini M; Karakiewicz PI; Teoh JY; Miki J; Kimura T; Shariat SF Eur Urol Focus; 2023 May; 9(3):463-479. PubMed ID: 36517409 [TBL] [Abstract][Full Text] [Related]
3. Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial. Gallagher K; Bhatt N; Clement K; Zimmermann E; Khadhouri S; MacLennan S; Kulkarni M; Gaba F; Anbarasan T; Asif A; Light A; Ng A; Chan V; Nathan A; Cooper D; Aucott L; Marcq G; Teoh JY; Hensley P; Duncan E; Goulao B; O'Brien T; Nielsen M; Mariappan P; Kasivisvanathan V JMIR Res Protoc; 2023 Jun; 12():e42254. PubMed ID: 37318875 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study). Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis. Li S; Zeng XT; Ruan XL; Wang XH; Guo Y; Yang ZH Exp Ther Med; 2012 Oct; 4(4):685-692. PubMed ID: 23170127 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis. Krajewski W; Nowak Ł; Poletajew S; Tukiendorf A; Moschini M; Mari A; Di Trapani E; Xylinas E; Kiełb P; Wełna M; Zdrojowy R J Endourol; 2020 Aug; 34(8):795-804. PubMed ID: 32336149 [No Abstract] [Full Text] [Related]
7. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
9. Chemoresection by mitomycin C compared to transurethral resection of bladder tumor in patients with recurrent nonmuscle-invasive bladder cancer: A systematic review and meta-analysis. Deb AA; Agag A; Naushad N; Krishnamoorthy R; Serag H Turk J Urol; 2021 Jul; 47(4):260-269. PubMed ID: 35118949 [TBL] [Abstract][Full Text] [Related]
10. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme. Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D; Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321 [TBL] [Abstract][Full Text] [Related]
11. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J; Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749 [TBL] [Abstract][Full Text] [Related]
12. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Li C; Gao L; Zhang J; Yang X; Liu C Lasers Med Sci; 2020 Jul; 35(5):1025-1034. PubMed ID: 32006262 [TBL] [Abstract][Full Text] [Related]
13. Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Perlis N; Zlotta AR; Beyene J; Finelli A; Fleshner NE; Kulkarni GS Eur Urol; 2013 Sep; 64(3):421-30. PubMed ID: 23830475 [TBL] [Abstract][Full Text] [Related]
14. Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis. Huang D; Jin YH; Weng H; Huang Q; Zeng XT; Wang XH Front Oncol; 2019; 9():121. PubMed ID: 30881921 [No Abstract] [Full Text] [Related]
15. Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer. Karsh L; Shore N; Soloway M; Bhat G; Reddy G; Leu SY; Witjes JA Bladder Cancer; 2018 Jul; 4(3):293-301. PubMed ID: 30112440 [TBL] [Abstract][Full Text] [Related]
16. A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer. Li K; Xu Y; Tan M; Xia S; Xu Z; Xu D Lasers Med Sci; 2019 Feb; 34(1):85-92. PubMed ID: 30171441 [TBL] [Abstract][Full Text] [Related]
17. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG). Contieri R; Soloway MS; Gontero P; Herr H; Kassouf W; Mertens LS; Moschini M; O'Donnell M; Palou J; Psutka SP; Rouprêt M; Teoh JYC; Kamat AM Eur Urol Oncol; 2024 Aug; ():. PubMed ID: 39218742 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transurethral laser therapy for bladder cancer: a systematic review and meta-analysis. Bai Y; Liu L; Yuan H; Li J; Tang Y; Pu C; Han P World J Surg Oncol; 2014 Sep; 12():301. PubMed ID: 25256383 [TBL] [Abstract][Full Text] [Related]
19. Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation. Tanimoto R; Saika T; Ebara S; Kobayashi Y; Nasu R; Yamada D; Takamoto H; Miyaji Y; Nasu Y; Tsushima T; Kumon H World J Urol; 2018 Jun; 36(6):889-895. PubMed ID: 29387931 [TBL] [Abstract][Full Text] [Related]
20. Monopolar versus bipolar transurethral resection of bladder tumors: An updated systematic review and meta-analysis of existing studies. Xu J; Zheng J; Ma Y Medicine (Baltimore); 2020 Aug; 99(34):e21768. PubMed ID: 32846804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]